Document is current
Any future updates will be listed below
-
Authors
Hausmann, David https://orcid.org/0000-0002-0571-4710
Hoffmann, Dirk C. https://orcid.org/0000-0003-1370-1933
Venkataramani, Varun https://orcid.org/0000-0002-2927-0886
Jung, Erik
Horschitz, Sandra
Tetzlaff, Svenja K.
Jabali, Ammar
Hai, Ling
Kessler, Tobias https://orcid.org/0000-0001-8350-7074
Azoŕin, Daniel D.
Weil, Sophie
Kourtesakis, Alexandros
Sievers, Philipp https://orcid.org/0000-0003-3237-6021
Habel, Antje https://orcid.org/0000-0003-3472-4165
Breckwoldt, Michael O. https://orcid.org/0000-0002-9980-2390
Karreman, Matthia A.
Ratliff, Miriam https://orcid.org/0000-0002-9464-6544
Messmer, Julia M. https://orcid.org/0000-0001-7858-1501
Yang, Yvonne
Reyhan, Ekin https://orcid.org/0000-0002-2109-0186
Wendler, Susann
Löb, Cathrin
Mayer, Chanté
Figarella, Katherine https://orcid.org/0000-0003-3305-9167
Osswald, Matthias
Solecki, Gergely
Sahm, Felix https://orcid.org/0000-0001-5441-1962
Garaschuk, Olga
Kuner, Thomas
Koch, Philipp https://orcid.org/0000-0003-3713-8786
Schlesner, Matthias https://orcid.org/0000-0002-5896-4086
Wick, Wolfgang https://orcid.org/0000-0002-6171-634X
Winkler, Frank https://orcid.org/0000-0003-4892-6104
- License Information
-
More Information
Article History
Received: 4 February 2021
Accepted: 3 November 2022
First Online: 14 December 2022
Competing interests
: E.J., M.O., W.W. and F.W. are inventors on patent no. WO2017020982A1 titled ‘Agents for Use in the Treatment of Glioma’. F.W. reports a research collaboration with DC Europa Limited, GlaxoSmithKline, Genentech and Boehringer. F.W. is co-founder of DC Europa Limited. M.R. reports a research grant from Novocure and honoraria, consulting fees and lecture fees from Novocure and Alexxion (now AstraZeneca). G.S. is an employee of Carl Zeiss Microscopy GmbH. F.S. received honoraria from Bayer and Illumina. W.W. is an inventor and patent holder on ‘Peptides for use in Treating or Diagnosing IDH1R132H Positive Cancers’ (patent no. EP2800580B1) and ‘Cancer Therapy with an Oncolytic Virus Combined with a Checkpoint Inhibitor’ (US11027013B2). He has consulted for Apogenix, AstraZeneca, Bayer, Enterome, Medac, MSD and Roche/Genentech, with honoraria paid to the Medical Faculty at the University of Heidelberg.
